Clinical Trial Update: Neuroprotection With Riluzole Patients With Early Multiple Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating riluzole for neuroprotection in early multiple sclerosis has completed, and results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Riluzole (riluzole)

Snippet

Sponsor: University of California, San Francisco | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2014-04-09